GSN and Barrett esophagus: Geloslin, a known tumour suppressor gene, is a multifunctional regulator of cell structure and GSN downregulation in a glycoprotein panel is a diagnostic biomarker for Barrett’s oesophagus requiring clinical intervention [59].